Clinilabs, LLC, a leading full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and medical technology development, today announced the appointments of ...

Artificial intelligence is playing an increasingly vital role in modern medicine, particularly in interpreting medical images to help clinicians assess disease severity, guide treatment decisions and ...

PolarSeal®, the flexible medical device partner, today announces the appointment of Chris Locke as Chief Technology Officer (CTO) – a key strategic move that reinforces its commitment to enabling ...

Small- to medium-sized AAAs (3.5–5.0 cm in women, 3.5–5.5 cm in men) are typically managed with imaging surveillance, as no proven therapeutic interventions currently exist for this patient group.

Strong teeth and healthy gums don’t happen by chance. They come from steady care, done every single day. What you do in small moments adds up to a big difference over time. Most problems don’t start ...

Seed, a microbiome science company, today announced the nationwide retail launch of its clinically validated microbiome innovations at Sprouts Farmers Market. Beginning this week, Seed’s DS-01® Daily ...

NanoHive Medical, LLC, a leading innovative 3D printed spinal implant technology company is pleased to announce that the company has secured the exclusive sublicense of DirectSync Surgical’s ...

The first cohort in the ongoing clinical Phase 2a study EXIST evaluated a lower dose of exidavnemab compared to placebo in patients with Parkinson’s disease. An interim safety review showed that ...

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical ...

Car accidents don’t just wreck your vehicle—they can wreck your body, your finances, and your peace of mind. In Tempe, where major roadways like Loop 101 and US-60 intersect with high-volume local ...

Glytec, the leading provider of an AI-powered technology platform for diabetes and related conditions, today announced it has closed a $36 million growth investment led by Savitr Capital and Hayfin ...

Neurodon Corp., a leader in the development of endoplasmic reticulum (ER) stress-targeted therapeutics for diabetes and neurodegeneration, welcomes Frederick Beddingfield, III, M.D., Ph.D., a 22-year ...